by katehumphrey | May 25, 2023 1:56 pm | Biotechnology |
Pyxis Oncology announced on May 24 that it acquired Apexigen, Inc. for $16 million. Founded in 2010, Apexigen, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology. Pyxis Oncology is building a differentiated portfolio of biologics, including...
Read More »